Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02803970

KOrean Borderline Ovarian Tumor (KOBOT) Registry

Establishing the Registry of Korean Patients With Borderline Ovarian Tumors

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Kangbuk Samsung Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Detailed description

The researchers retrospectively collected data on Korean patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. And the researchers prospectively will collect data on all Korean patients with BOTs at institutions where placed in the Republic of Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.

Conditions

Timeline

Start date
1994-12-01
Primary completion
2040-12-01
Completion
2040-12-01
First posted
2016-06-17
Last updated
2019-04-03

Locations

4 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02803970. Inclusion in this directory is not an endorsement.